ES2151570T3 - Preparacion de alfa-1-antiquimotripsina. - Google Patents

Preparacion de alfa-1-antiquimotripsina.

Info

Publication number
ES2151570T3
ES2151570T3 ES95111304T ES95111304T ES2151570T3 ES 2151570 T3 ES2151570 T3 ES 2151570T3 ES 95111304 T ES95111304 T ES 95111304T ES 95111304 T ES95111304 T ES 95111304T ES 2151570 T3 ES2151570 T3 ES 2151570T3
Authority
ES
Spain
Prior art keywords
antiquimotripsina
alfa
preparation
human alpha
act
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95111304T
Other languages
English (en)
Inventor
Grace C Tsay
Neal K H Cheung
Jeffrey D Bettencourt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Application granted granted Critical
Publication of ES2151570T3 publication Critical patent/ES2151570T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA AL 1 -ANTIQUIMIOTRIPSINA HUMANA (ACT) PUEDE PURIFICARSE A PARTIR DE SOLUCIONES QUE CONTIENEN UN INHIBIDOR DE LA {AL}{SUB, 1}PROTEINASA HUMANA (PI) Y ANTITROMBINA III (AT-III) USANDO PASOS DE ABSORCION CROMATOGRAFICA CON UN PH Y UNA CONDUCTIVIDAD CUIDADOSAMENTE CONTROLADOS. LA ACT SEPARADA RETIENE LA CAPACIDAD INHIBIDORA "IN VITRO" Y TIENE UN USO TERAPEUTICO POTENCIAL.
ES95111304T 1994-07-29 1995-07-19 Preparacion de alfa-1-antiquimotripsina. Expired - Lifetime ES2151570T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/282,860 US5561108A (en) 1994-07-29 1994-07-29 Preparation of α1 -antichymotrypsin

Publications (1)

Publication Number Publication Date
ES2151570T3 true ES2151570T3 (es) 2001-01-01

Family

ID=23083438

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95111304T Expired - Lifetime ES2151570T3 (es) 1994-07-29 1995-07-19 Preparacion de alfa-1-antiquimotripsina.

Country Status (12)

Country Link
US (1) US5561108A (es)
EP (1) EP0694562B1 (es)
JP (1) JP3693391B2 (es)
KR (1) KR100433115B1 (es)
CN (1) CN1175102C (es)
AT (1) ATE197461T1 (es)
CA (1) CA2154982C (es)
DE (1) DE69519338T2 (es)
DK (1) DK0694562T3 (es)
ES (1) ES2151570T3 (es)
GR (1) GR3035340T3 (es)
PT (1) PT694562E (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110964707A (zh) * 2019-12-31 2020-04-07 江西浩然生物制药有限公司 一种糜蛋白酶的提取纯化方法

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP751198A0 (en) * 1998-12-04 1999-01-07 Csl Limited Purification of A1-proteinase inhibitor
ES2346400T3 (es) * 1999-04-30 2010-10-15 Neurotrophincell Pty Ltd Xenotransplante para la terapia del snc.
US20050265977A1 (en) * 1999-04-30 2005-12-01 Elliott Robert B Xenotransplant for CNS therapy
US20090047325A1 (en) * 1999-04-30 2009-02-19 Neurotrophincell Pty. Limited Xenotransplant for cns therapy
ES2272482T3 (es) * 2000-01-20 2007-05-01 Diabcell Pty Limited Preparacion y xenotransplante de islotes porcinos.
AU1112202A (en) * 2000-10-17 2002-04-29 Diatranz Ltd Preparation and xenotransplantation or porcine islets
NZ515310A (en) * 2001-11-07 2004-08-27 Diabcell Pty Ltd Methods of treatment and delivery modes
WO2004113516A1 (en) * 2003-06-24 2004-12-29 Diabcell Pty Limited Porcine islets cultured with porcine sertoli cells for xenotransplantation
NZ540597A (en) * 2005-06-08 2007-02-23 Neurotrophincell Pty Ltd A method for preventing the onset of type I diabetes comprising administering an implantable composition comprising living choroid plexus cells
CN103160486A (zh) * 2013-04-02 2013-06-19 黑龙江迪龙制药有限公司 一种猪凝血酶的制备方法
CN112062833A (zh) * 2020-10-09 2020-12-11 国药集团武汉血液制品有限公司 一种从血浆组分ⅳ沉淀中提取人血白蛋白的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0067293B1 (en) * 1981-05-01 1986-06-25 Medical Research Institute of San Francisco Method for isolating alpha-1-antitrypsin
US4379087A (en) * 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US5079336A (en) * 1989-06-23 1992-01-07 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110964707A (zh) * 2019-12-31 2020-04-07 江西浩然生物制药有限公司 一种糜蛋白酶的提取纯化方法

Also Published As

Publication number Publication date
CN1175102C (zh) 2004-11-10
DK0694562T3 (da) 2001-01-02
DE69519338T2 (de) 2001-05-31
CN1133885A (zh) 1996-10-23
JPH08176197A (ja) 1996-07-09
GR3035340T3 (en) 2001-05-31
AU700921B2 (en) 1999-01-14
AU2714395A (en) 1996-02-08
JP3693391B2 (ja) 2005-09-07
EP0694562A1 (en) 1996-01-31
KR100433115B1 (ko) 2004-08-30
EP0694562B1 (en) 2000-11-08
ATE197461T1 (de) 2000-11-11
PT694562E (pt) 2001-04-30
DE69519338D1 (de) 2000-12-14
CA2154982C (en) 2008-03-18
US5561108A (en) 1996-10-01
CA2154982A1 (en) 1996-01-30
KR960004367A (ko) 1996-02-23

Similar Documents

Publication Publication Date Title
DE69422997D1 (de) Blutsauerstoffsystem und herstellverfahren
ES2191102T3 (es) Heterociclos de peptidilo utiles en el tratamiento de las afecciones relacionadas con la trombina.
HK1072372A1 (en) Alpha-1 proteinase inhibitor preparation
DE69422070T2 (de) Kompakter Blut-Kultur-Apparat
MX9405383A (es) Imidazo(4,5-c) piridin-4-aminas.
ES2151570T3 (es) Preparacion de alfa-1-antiquimotripsina.
IL138665A0 (en) Peptide factor
ITRM920688A0 (it) Apparecchio per l'analisi topografica di superfici anatomiche, in particolare della cornea
DE59406374D1 (de) Hydroxamsäuren und hydroxamsäureether sowie ihre verwendung als komplexbildner
IT8248514A0 (it) Catetere esterno per raccogliere l'urina in individui di sesso maschile, e procedimento per la sua fabbricazione
IT8883551A0 (it) Procedimento per l'estrazione e la purificazione di dna
IT8419730A0 (it) Procedimento per la trasformazione quantitativa di teicoplanina a2fattore 1 in teicoplanina a2fattore 3.
ITRM920658A0 (it) Procedimento per la purificazione della proteina endotelina
IT8622548A0 (it) Procedimento d'epurazione e di deodorizzazione di gas e installazione per la messa in opera di questo procedimento.
DK0904070T3 (da) Anvendelse af buckminsterfulleren til behandling af neurotoksiske læsioner
ATE146526T1 (de) Neues thrombininhibitorisches protein aus zecken
KR970023499U (ko) 생물학적 순산소 개방형 폐수 처리장치
FR2633614B1 (fr) Procede de monohalogenation en (alpha) des groupements carbonyles des cetones
ITMI942076A0 (it) Procedimento per la riduzione del contenuto di nicotina mediante l'azione di microrganismi
IT1274015B (it) Uso del ceruletide (takus) nel trattamento della psoriasi
KR940022143U (ko) 공기 청정기의 전리부 구조
ITCT940005A0 (it) Terapia dei tumori fondata sull'impiego di enzimi
KR950033901U (ko) 본체 이중분리형 가습기
ID15808A (id) Penggunaan protease dibidang kedokteran
ITMI930768A0 (it) Dichiarazione ai sensi art. 4 del d.m. del 3 aprile 1981 (n. 2)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 694562

Country of ref document: ES